Compare McKesson Corporation (MCK) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Block Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Block Inc trades at $80.32 (market cap $47.19B). The key difference: McKesson Corporation is far larger — about 2.1× Block Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Block Inc pays none. Which is the better fit depends on your goals.
| MCK | XYZ | |
|---|---|---|
Market Cap | $97.35B | $47.19B |
Sector | Health | Technology |
52-Week High | $995.69 | $81.81 |
52-Week Low | $659.01 | $49.04 |
Enterprise Value | $101.98B | $42.06B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
XYZ trades at $80.38, up 0.55% today, with a bullish technical signal and strong analyst consensus. Recent Q1 2026 earnings beat expectations, but net income margin fell to 3.3% in 2025. The stock is supported by positive sentiment from Zacks upgrades and momentum coverage, though it faces risks from a recent $45 million settlement and mixed cash flow trends.
The outlook is cautiously optimistic, with a consensus price target of $89.64 offering ~12% upside. Key opportunities include earnings growth and Cash App strength, but risks involve credit losses, regulatory scrutiny, and a high P/E ratio of 61.95. Institutional selling and insider sales add near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
